Calendar Daewon Pharmaceutical Co., Ltd.

Equities

A003220

KR7003220001

End-of-day quote Korea S.E. 03:30:00 14/05/2024 am IST 5-day change 1st Jan Change
15,200 KRW +3.47% Intraday chart for Daewon Pharmaceutical Co., Ltd. +1.74% -2.94%

Chart calendar Daewon Pharmaceutical Co., Ltd.

0ee6241e5e2d187129f088d83287ffb4.f8RtR3AhRrsfyaMSyQVV6M-lKyqq67wHa6OmBN4Ki-4.PJwjN0ZwJPRr_PsjqFItrbzPE1n_qs9qMsnBQ4dp0pgosz8LPFMgjC-x0A~9a40a3db313e73d6fb8e448e206a5ef6

Upcoming events on Daewon Pharmaceutical Co., Ltd.

13/08/2024 Q2 2024 Earnings Release (Projected)
13/11/2024 Q3 2024 Earnings Release (Projected)
19/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Daewon Pharmaceutical Co., Ltd.

13/05/2024 Q1 2024 Earnings Release (Projected)
15/05/2023 Q1 2023 Earnings Release
17/03/2023 Q4 2022 Earnings Release
11/11/2022 Q3 2022 Earnings Release
16/08/2022 Interim 2022 Earnings Release
16/05/2022 Q1 2022 Earnings Release
17/08/2021 Interim 2021 Earnings Release
17/05/2021 Q1 2021 Earnings Release
12/03/2021 FY 2020 Earnings Release
30/03/2020 FY 2019 Earnings Release
14/11/2019 Q3 2019 Earnings Release
15/05/2019 Q1 2019 Earnings Release
13/08/2018 Interim 2018 Earnings Release
14/02/2018 FY 2017 Earnings Release

Past dividends on Daewon Pharmaceutical Co., Ltd.

27/12/2023 Annual 300 KRW
28/12/2022 Annual 350 KRW
29/12/2021 Annual 200 KRW
29/12/2020 Annual 160 KRW
27/12/2019 Annual 260 KRW
27/12/2018 Annual 260 KRW
27/12/2017 Annual 260 KRW
28/12/2016 Annual 260 KRW
29/12/2015 Annual 200 KRW
29/12/2014 Annual 150 KRW

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Billions KRW
Released
Forecast
Spread
318
315
0.95%
309


354
356
-0.51%
479
484
-1.06%
527
520
1.43%

604

EBITDA
Billions KRW
Released
Forecast
Spread
44,2
48,0
-7.87%
0,00


37,2
32,0
16.35%
62,4
67,7
-7.82%
49,8
55,3
-9.96%

67,0

EBIT
Billions KRW
Released
Forecast
Spread
35,1
35,7
-1.52%
0,00


19,5
14,0
39.03%
43,0
48,3
-11.02%
32,2
36,2
-10.96%

50,9

Earnings before Tax (EBT)
Billions KRW
Released
Forecast
Spread
35,4
36,0
-1.74%
0,00


17,2
11,0
56.17%
38,1
45,7
-16.48%
25,8
33,7
-23.28%

41,0

Net income
Billions KRW
Released
Forecast
Spread
27,3
27,1
0.7%
18,6


6,65
8,00
-16.83%
31,3
36,3
-13.9%
23,9
35,0
-31.57%

32,0

EPS
KRW
Released
Forecast
Spread
1 303
1 250
4.22%
0,00


339
379
-10.47%
1 479
1 691
-12.52%
1 110
1 592
-30.28%

1 432

Announcement Date12/03/2004/02/2110/02/2209/02/2314/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Billions KRW
Released
Forecast
Spread



117
108
8.58%
122
107
14.43%
123
126
-2.57%
124
136
-8.76%
133
123
7.98%
129
130
-0.71%
141
133
5.59%

135


151


153


165

EBIT
Billions KRW
Released
Forecast
Spread



10,2
10,2
-0.38%
14,6
8,98
62.47%
4,31
9,73
-55.69%
8,98
14,0
-35.86%
10,1
11,1
-9.64%
6,74
11,0
-38.89%
6,45
10,4
-37.98%

14,6


11,9


12,2


12,3

Net income
Billions KRW
Released
Forecast
Spread
10,5


7,40
8,50
-12.92%
11,1
6,10
81.51%









5,46
7,90
-30.94%
0,75
8,00
-90.63%












EPS
KRW
Released
Forecast
Spread
495



































Announcement Date16/05/2216/08/2211/11/2209/02/2315/05/2311/08/2314/11/2314/03/24----

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A003220 Stock
  4. Calendar Daewon Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW